Last updated on December 2018

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]


Brief description of study

The primary objective of this pragmatic study is to compare the time to first moderate or severe COPD exacerbation in patients, not controlled on their current therapy, randomized to Stiolto Respimat versus triple therapy over 12 months of treatment

The secondary objectives of this study include:

  1. To compare the annual rate of moderate or severe COPD exacerbations for patients on Stiolto Respimat with patients on triple therapy.
  2. To compare the time to first severe COPD exacerbation in both treatment arms.
  3. To compare the annual rate of severe COPD exacerbations in both treatment arms.
  4. To compare the proportion of patients with moderate or severe COPD exacerbations in both treatment arms.

Clinical Study Identifier: NCT03265145

Contact Investigators or Research Sites near you

Start Over

John Bertsch

Ohio Clinical Research, LLC
Willoughby Hills, OH United States
2.27miles
  Connect »

Jeffrey Renston

Pulmonary Medicine
South Euclid, OH United States
7.65miles
  Connect »